Mirum Pharmaceuticals, Inc. SEC filings MIRM
Mirum Pharmaceuticals, Inc. has 674 filings in SEC EDGAR's recent list, going back to Nov 20, 2018. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Other events
|
Oct 26, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Other events
|
Oct 13, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Other events
|
Sep 28, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 8, 2026 | Sep 2, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
May 18, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Other events
|
May 4, 2026 | May 4, 2026 |
| 8-K |
Current report
Other events
|
Apr 27, 2026 | Apr 27, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Dec 31, 2025 |
| 8-K/A | Amended current report | Apr 8, 2026 | Jan 23, 2026 |
| S-3ASR | Automatic shelf registration | Feb 25, 2026 | — |
| S-8 | Employee stock plan registration | Feb 25, 2026 | — |
| 10-K | Annual report | Feb 25, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2026 | Feb 25, 2026 |
| D | Filing | Jan 29, 2026 | — |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure, Other events
|
Jan 26, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Dec 19, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 19, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Dec 8, 2025 | Dec 6, 2025 |
| 8-K |
Current report
Other events
|
Nov 17, 2025 | Nov 17, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| S-8 | Employee stock plan registration | Sep 9, 2025 | — |
| S-3ASR | Automatic shelf registration | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2025 | May 29, 2025 |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| ARS | Annual report to shareholders | Apr 14, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 14, 2025 | — |
| DEF 14A | Proxy statement | Apr 14, 2025 | Apr 14, 2025 |
| S-8 | Employee stock plan registration | Feb 26, 2025 | — |
| 10-K | Annual report | Feb 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Other events
|
Jun 17, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Other events
|
May 31, 2024 | May 31, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| ARS | Annual report to shareholders | Apr 23, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| DEF 14A | Proxy statement | Apr 23, 2024 | Apr 23, 2024 |
| S-8 | Employee stock plan registration | Mar 15, 2024 | — |
| 10-K | Annual report | Mar 15, 2024 | Dec 31, 2023 |
| NT 10-K | Filing | Feb 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 16, 2024 | Jan 11, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Other events
|
Dec 18, 2023 | Dec 18, 2023 |
| S-8 | Employee stock plan registration | Nov 2, 2023 | — |
| 424B5 | Prospectus supplement | Nov 2, 2023 | — |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K/A | Amended current report | Nov 2, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Other events
|
Oct 17, 2023 | Oct 17, 2023 |
| S-3ASR | Automatic shelf registration | Oct 13, 2023 | — |
| 8-K |
Current report
Other events
|
Oct 13, 2023 | Oct 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Sep 5, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2023 | Aug 24, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 17, 2023 | Jul 16, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2023 | Jun 12, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| ARS | Annual report to shareholders | May 1, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Apr 17, 2023 | Apr 12, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Apr 12, 2023 | Apr 12, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 6, 2023 | Apr 5, 2023 |
| 8-K |
Current report
Other events
|
Mar 10, 2023 | Mar 10, 2023 |
| S-8 | Employee stock plan registration | Mar 9, 2023 | — |
| 10-K | Annual report | Mar 8, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2023 | Mar 8, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Jan 9, 2023 | Jan 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 19, 2022 | Dec 16, 2022 |
| 8-K |
Current report
Other events
|
Dec 13, 2022 | Dec 13, 2022 |
| 8-K |
Current report
Other events
|
Nov 29, 2022 | Nov 29, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 24, 2022 | Oct 24, 2022 |
| S-3ASR | Automatic shelf registration | Sep 9, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2022 | Sep 1, 2022 |
| 424B5 | Prospectus supplement | Aug 10, 2022 | — |
| 8-K |
Current report
Other events
|
Aug 10, 2022 | Aug 9, 2022 |
| 424B5 | Prospectus supplement | Aug 9, 2022 | — |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| EFFECT | Filing | Jun 9, 2022 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jun 6, 2022 | Jun 2, 2022 |
| CORRESP | Letter to the SEC | Jun 6, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2022 | — |
| S-3 | Shelf registration | May 25, 2022 | — |
| 8-K |
Current report
Other events
|
May 23, 2022 | May 20, 2022 |
| 10-Q | Quarterly report | May 5, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| DEF 14A | Proxy statement | Apr 22, 2022 | Jun 2, 2022 |
| S-8 | Employee stock plan registration | Mar 9, 2022 | — |
| 10-K | Annual report | Mar 9, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2022 | Mar 9, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 11, 2022 | Jan 11, 2022 |
| 8-K |
Current report
Acquisition or sale of assets
|
Dec 22, 2021 | Dec 22, 2021 |
| 8-K |
Current report
Material agreement
|
Nov 19, 2021 | Nov 16, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 29, 2021 | Sep 28, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 20, 2021 | Aug 16, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jun 9, 2021 | Jun 4, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| DEFA14A | Additional proxy material | Apr 14, 2021 | — |
| DEF 14A | Proxy statement | Apr 14, 2021 | Jun 4, 2021 |
| 8-K |
Current report
Other events
|
Mar 29, 2021 | Mar 29, 2021 |
| S-8 | Employee stock plan registration | Mar 9, 2021 | — |
| 10-K | Annual report | Mar 9, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2021 | Mar 9, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2021 | Jan 12, 2021 |
| D | Filing | Dec 30, 2020 | — |
| 8-K |
Current report
Other events
|
Dec 15, 2020 | Dec 14, 2020 |
| 424B5 | Prospectus supplement | Dec 15, 2020 | — |
| 424B5 | Prospectus supplement | Dec 14, 2020 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 10, 2020 | Dec 8, 2020 |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 12, 2020 |
| EFFECT | Filing | Aug 12, 2020 | — |
| S-3/A | Filing | Aug 10, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2020 | — |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| S-3 | Shelf registration | Aug 3, 2020 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2020 | Jun 11, 2020 |
| S-8 | Employee stock plan registration | May 7, 2020 | — |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| DEFA14A | Additional proxy material | Apr 29, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 11, 2020 |
| 10-K | Annual report | Mar 12, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2020 | Mar 12, 2020 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 14, 2020 | Jan 10, 2020 |
| 424B4 | Prospectus | Jan 9, 2020 | — |
| EFFECT | Filing | Jan 8, 2020 | — |
| CORRESP | Letter to the SEC | Jan 6, 2020 | — |
| CORRESP | Letter to the SEC | Jan 6, 2020 | — |
| S-1 | Registration statement | Jan 6, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2019 | — |
| 8-K |
Current report
Officer or director change
|
Dec 27, 2019 | Dec 24, 2019 |
| DRS | Filing | Dec 27, 2019 | — |
| 10-Q | Quarterly report | Nov 6, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2019 | Nov 6, 2019 |
| S-8 | Employee stock plan registration | Aug 28, 2019 | — |
| 10-Q | Quarterly report | Aug 28, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 28, 2019 | Aug 28, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 25, 2019 | Jul 22, 2019 |
| 424B4 | Prospectus | Jul 18, 2019 | — |
| EFFECT | Filing | Jul 17, 2019 | — |
| CERT | 8a cert | Jul 16, 2019 | — |
| CORRESP | Letter to the SEC | Jul 15, 2019 | — |
| CORRESP | Letter to the SEC | Jul 15, 2019 | — |
| 8-A12B | Filing | Jul 15, 2019 | — |
| CORRESP | Letter to the SEC | Jul 12, 2019 | — |
| S-1/A | Amended registration statement | Jul 12, 2019 | — |
| SEC STAFF LETTER | Filing | Jul 10, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2019 | — |
| CORRESP | Letter to the SEC | Jul 8, 2019 | — |
| S-1/A | Amended registration statement | Jul 8, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2019 | — |
| CORRESP | Letter to the SEC | Jun 27, 2019 | — |
| CORRESP | Letter to the SEC | Jun 21, 2019 | — |
| S-1 | Registration statement | Jun 21, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2019 | — |
| DRSLTR | Filing | May 24, 2019 | — |
| DRS/A | Filing | May 24, 2019 | — |
| UPLOAD | Letter from the SEC | May 16, 2019 | — |
| SEC STAFF LETTER | Filing | May 7, 2019 | — |
| DRS | Filing | Apr 18, 2019 | — |
| D | Filing | Nov 20, 2018 | — |
Showing 196 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIRM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Foster City, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1759425
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.